Matches in SemOpenAlex for { <https://semopenalex.org/work/W2400152360> ?p ?o ?g. }
Showing items 1 to 60 of
60
with 100 items per page.
- W2400152360 endingPage "34" @default.
- W2400152360 startingPage "225" @default.
- W2400152360 abstract "Doxifluridine, a new fluorouracil analog with a low myelosuppressive effect, has recently been subject to various disease-oriented, Phase II trials. For the present evaluation of drug tolerance, the Phase II data of 114 patients having received 376 doxifluridine cycles has been used. The treatment cycles consisted of 5 daily intravenous injections of 4,000 mg/m2 non-pretreated patients, and 3,000 mg/m2 in pretreated patients. Previous observations showing that doxifluridine is less myelotoxic than fluorouracil have been confirmed. 54% of the patients had no leucopenia (maintaining WBC counts over 3,000/mm3 and 90% had no thrombopenia (platelets not lower than 100,000/mm3) throughout treatment. However, a WHO grade 4 hematologic toxicity was observed in 9 patients, and 2 toxic deaths were related to severe granulocytopenia and sepsis. Digestive tract toxicity was similar and equally frequent as the one observed with fluorouracil: mucositis with oral ulcerations (19%), nausea and vomiting requiring specific treatment (8%) and severe but never hemorrhagic diarrhoea (5%). Neurologic toxicity was frequent, with 20% of patients complaining of somnolence and/or peripheral neuropathy, 7% of impaired consciousness and 1% of WHO grade 4 cerebellar ataxia. Among the 10% of patients with cardiac symptoms, 6% were benign and transient arrhythmias, and 4% were severe, including 1 myocardial infarction, 1 spontaneously reversible cardiac arrest and 2 ventricular fibrillations successfully treated with cardioversion. In spite of its encouraging antitumor activity and its good hematologic tolerance, intravenous doxifluridine, as used in this study, cannot be recommended because of the observed neurologic and cardiac toxicity. Oral doxifluridine is presently under investigation with preliminary results suggesting a lack of neuro- or cardiotoxicity." @default.
- W2400152360 created "2016-06-24" @default.
- W2400152360 creator A5068928419 @default.
- W2400152360 creator A5081729071 @default.
- W2400152360 creator A5090294153 @default.
- W2400152360 date "1990-01-01" @default.
- W2400152360 modified "2023-10-16" @default.
- W2400152360 title "[Doxifluridine toxicity, a fluorouracil analog with low myelosuppressive effect]." @default.
- W2400152360 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/2140280" @default.
- W2400152360 hasPublicationYear "1990" @default.
- W2400152360 type Work @default.
- W2400152360 sameAs 2400152360 @default.
- W2400152360 citedByCount "1" @default.
- W2400152360 crossrefType "journal-article" @default.
- W2400152360 hasAuthorship W2400152360A5068928419 @default.
- W2400152360 hasAuthorship W2400152360A5081729071 @default.
- W2400152360 hasAuthorship W2400152360A5090294153 @default.
- W2400152360 hasConcept C126322002 @default.
- W2400152360 hasConcept C2776694085 @default.
- W2400152360 hasConcept C2778384902 @default.
- W2400152360 hasConcept C2778496288 @default.
- W2400152360 hasConcept C2780456651 @default.
- W2400152360 hasConcept C2780580376 @default.
- W2400152360 hasConcept C2780852908 @default.
- W2400152360 hasConcept C29730261 @default.
- W2400152360 hasConcept C42219234 @default.
- W2400152360 hasConcept C71924100 @default.
- W2400152360 hasConcept C90924648 @default.
- W2400152360 hasConceptScore W2400152360C126322002 @default.
- W2400152360 hasConceptScore W2400152360C2776694085 @default.
- W2400152360 hasConceptScore W2400152360C2778384902 @default.
- W2400152360 hasConceptScore W2400152360C2778496288 @default.
- W2400152360 hasConceptScore W2400152360C2780456651 @default.
- W2400152360 hasConceptScore W2400152360C2780580376 @default.
- W2400152360 hasConceptScore W2400152360C2780852908 @default.
- W2400152360 hasConceptScore W2400152360C29730261 @default.
- W2400152360 hasConceptScore W2400152360C42219234 @default.
- W2400152360 hasConceptScore W2400152360C71924100 @default.
- W2400152360 hasConceptScore W2400152360C90924648 @default.
- W2400152360 hasIssue "3" @default.
- W2400152360 hasLocation W24001523601 @default.
- W2400152360 hasOpenAccess W2400152360 @default.
- W2400152360 hasPrimaryLocation W24001523601 @default.
- W2400152360 hasRelatedWork W1980701009 @default.
- W2400152360 hasRelatedWork W1981794048 @default.
- W2400152360 hasRelatedWork W2023804869 @default.
- W2400152360 hasRelatedWork W2072252734 @default.
- W2400152360 hasRelatedWork W2093791334 @default.
- W2400152360 hasRelatedWork W2351330232 @default.
- W2400152360 hasRelatedWork W2370377759 @default.
- W2400152360 hasRelatedWork W2374367026 @default.
- W2400152360 hasRelatedWork W2468000090 @default.
- W2400152360 hasRelatedWork W2472155679 @default.
- W2400152360 hasVolume "77" @default.
- W2400152360 isParatext "false" @default.
- W2400152360 isRetracted "false" @default.
- W2400152360 magId "2400152360" @default.
- W2400152360 workType "article" @default.